Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design (Q35113331)
Jump to navigation
Jump to search
scientific article published on January 12, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design |
scientific article published on January 12, 2011 |
Statements
1 reference
Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design (English)
1 reference
George Wilding
1 reference
Amye Tevaarwerk
1 reference
Jens Eickhoff
1 reference
Rick Chappell
1 reference
Carolyn Sidor
1 reference
Jamie Arnott
1 reference
Howard Bailey
1 reference
William Schelman
1 reference
Glenn Liu
1 reference
12 January 2011
1 reference
1 reference
1 reference
1 reference
30
1 reference
3
1 reference
1039-1045
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference